12/08/2025
We continue to align and follow the evidence based medicine supporting the newborn dose of Hepatitis B vaccine.
A statement from American Academy of Pediatrics President, Dr. Susan J. Kressly:
The decision by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention to downgrade its recommendations to protect infants from hepatitis B is a dangerous move that will harm children.
The American Academy of Pediatrics continues to recommend routine hepatitis B vaccination for all newborns: All babies should receive a first dose of the hepatitis B vaccine within 24 hours of birth, a second dose at one to two months, and a third dose at six months. The pacing of these doses has been rigorously tested and proven to be safe and effective over several decades.
Vaccinating all newborns against hepatitis B effectively prevents transmission of the virus to newborns during childbirth, supports them to build immunity against potential childhood infections, and ensures long-term protection into adulthood from a virus that can cause serious liver disease and liver cancer. Infants and children can be exposed to this virus by close caregivers who may not know they are infected. Delaying the birth dose of the hepatitis B vaccine has no clear benefits and leaves children vulnerable to infection.
Click here to read the full statement: https://bit.ly/3Y9ZQJT
